Advertisement

Topics

Search Results for "Recall Promus Heart Stent"

04:46 EDT 3rd May 2016 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Failure HF

Heart Transplantation

Matching News

FDA Advisers Question Abbott's Dissolving Heart Stent

Abbott Labs is seeking FDA approval to sell a novel coronary stent that dissolves after it is implanted, but government scientists have raised questions about potential heart attack and blood clots ri...

FDA Advisors Question Abbott's Dissolving Heart Stent

Abbott Labs is seeking FDA approval to sell a novel coronary stent that dissolves after it is implanted, but government scientists have raised questions about potential heart attack and blood clots ri...

Health Highlights: March 16, 2016

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: FDA Panel Recommends Approval of Dissolving Heart Stent A dissolving heart stent should be appro...

FDA panel backs Abbott's dissolving heart stent

March 15 (Reuters) - FDA ADVISORY PANEL VOTES 9-0 IN FAVOR OF ABBOTT'S DISSOLVING HEART STENT (Reporting by Susan Kelly in Chicago)

Women undergoing PCI with newer DES have higher prevalence of chest pain

In a pooled analysis of the DUTCH PEERS and TWENTE randomized trials, the prevalence of clinically relevant chest pain was significantly higher among women undergoing PCI with newer-generation drug-el...

FDA advisers to weigh risks of Abbott’s dissolving stent

(Reuters) - U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after ...

FDA advisers to weigh risks of Abbott's dissolving stent

March 14 (Reuters) - U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolv...

Femoropopliteal stent thrombosis linked to treatment of CTO, in-stent restenosis lesions

Patients are more likely to develop femoropopliteal stent thrombosis when undergoing treatment for chronic total occlusions or in-stent restenosis lesions, according to an analysis of data from the XL...

Matching PubMed Articles

Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation.

This study sought to assess the incidence and clinical impact of stent fracture (SF) after the PROMUS Element platinum-chromium everolimus-eluting stent (PtCr-EES).

Investigation of fibrous cap stresses on vulnerable plaques leading to heart attacks.

Rupture-prone plaques in the coronary arteries, called ``vulnerable plaques'', are recognized as the key factor in acute myocardial infarction. Vulnerable plaques have a thin fibrous cap over a large ...

Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo.

Fibrin deposition and absent endothelium characterize unhealed stents that are at heightened risk of stent thrombosis. Optical coherence tomography (OCT) is increasingly used for assessing stent tissu...

Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction.

Drug-eluting stents (DES) reduce restenosis, as compared with bare-metal stents (BMS); however, the relationship between stent type and health status is unknown. We examined whether stent type was ass...

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium†.

Stent thrombosis (ST) is a rare but serious complication following percutaneous coronary intervention. Analysis of thrombus composition from patients undergoing catheter thrombectomy may provide impor...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement